Medical professionals always make it seem like they know what they’re doing.
And since they’re the experts and you’re the patient, it’s easy not to question them.
But the truth is, blindly following whatever advice mainstream medicine hands out could land you in a world of trouble. And guys, that’s especially true when it comes to recurring prostate cancer.
Because a key component of the “standard” treatment they’re about to sell you on… a step supposedly so crucial that it’s enshrined right in the guidelines… just FLUNKED a significant new study.
If you go through this prostate cancer treatment yourself, it probably won’t help you.
It could hurt you.
And most terrifying of all? It could even KILL you.
But there’s another way to tackle this disease. And it’s a solution that can help without hurting by wiping out the tumor without forcing you to face additional risks.
Dangers of prostate cancer treatment revealed
The experts ALMOST make it sound like you’re lucky to have had your cancer come back now. After all, they’ll explain, today you’ll get access to the latest and greatest modern science has to offer.
They’ll tell you the treatments they’re using were developed as the result of decades of research.
And they’ll insist their three-step approach not only can help you win a battle against prostate cancer but one where the disease returns for a second round.
Then, they’ll lay out the plan for tackling that recurrent tumor…
- hormone-blocking drugs
But now, they’ve been forced to admit the last step in their plan is likely a dangerous mistake.
The researchers behind the new study looked at data on 760 guys who battled prostate cancer for some 15-20 years and saw the disease return after surgery.
All of them were then moved onto step two for the recurring tumor and given radiation.
Then, for two years, half of them were given a drug called bicalutamide, which blocks testosterone, and half were given a placebo.
What happened next changed EVERYTHING we know about how prostate cancer is treated.
The deadly toll of hormone-blocking drugs
The guys given the hormone-blocking drug didn’t do better by any stretch.
In fact, they did worse. A LOT WORSE.
That was especially true for men with low PSA levels after prostate cancer surgery.
Those guys with lower PSA who were given the drug had a higher risk of…
- death from non-cancer causes
- severe heart events
- serious neurological problems
We’re not talking about some little bump in risk, either. The odds of facing these problems jumped by TWO, THREE, and even FOUR TIMES.
Adding insult to injury (and death), guys taking drugs to cut testosterone ALSO faced a higher risk of more immediate problems including sexual dysfunction and urinary incontinence.
Looks like it’s LONG past time to revise those dangerous prostate cancer treatment guidelines.
Heck, knowing what we know now, we may want to trash them altogether. After all, this is just more proof there’s no such thing as a one-size-fits-all formula for treating prostate cancer.
Go over these new findings with your doctor. And be sure to ask about the least invasive solutions along with the risks and benefits.
And never be afraid to get a second opinion. Especially from an integrative medicine doctor who can clearly lay out ALL of your best options for tackling your prostate cancer.
Latest posts by Alice Jacob (see all)
- Coronavirus could spread even after symptoms fade - April 4, 2020
- Keep calm and beat America’s ANXIETY pandemic - April 3, 2020
- Could D help keep us healthy in the age of CORONA? - April 3, 2020